Allogene Therapeutics, Inc.

By person

23 insiders · 152 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

TPG Group Holdings (SBS) Advisors, Inc. entity

10% owner

$12.15M (1)

$124.14M (22)

−$111.99M

18,716,306

5.42%

$39.68M

—

Belldegrun Arie

Director

$14.46M (5)

—

+$14.46M

7,670,959

2.22%

$16.26M

—

MOORE ALISON

Chief Technical Officer

—

$9.78M (16) scheduled

−$9.78M

672,731

0.1947%

$1.43M

+9,196%

Bhavnagri Veer

General Counsel

—

$5.22M (23) scheduled

−$5.22M

556,049

0.1609%

$1.18M

+52.7%

SCHMIDT ERIC THOMAS

Chief Financial Officer

—

$3.08M (19)

−$3.08M

2,015,034

0.5832%

$4.27M

+36.8%

Amado Rafael

EVP of R&D

—

$1.59M (9)

−$1.59M

541,946

0.1569%

$1.15M

+11,186%

Chang David D

President and CEO

$720.00K (1)

$1.82M (8)

−$1.10M

6,006,643

1.74%

$12.73M

+222.0%

PFIZER INC entity

10% owner

$1.00M (1)

—

+$1.00M

22,032,040

6.38%

$46.71M

—

WITTE OWEN N.

Director

$270.00K (1)

$1.23M (9)

−$962.22K

292,832

0.0848%

$620.80K

+47.3%

Humer Franz B

Director

$540.00K (1)

$46.10K (2)

+$493.90K

307,507

0.0890%

$651.91K

—

MESSEMER DEBORAH M.

Director

—

$197.45K (5) scheduled

−$197.45K

113,966

0.0330%

$241.61K

+1,644%

Kazam Joshua A

Director

$189.00K (1)

—

+$189.00K

398,463

0.1153%

$844.74K

−62.6%

Roberts Zachary

President and CEO

—

$184.60K (4)

−$184.60K

581,166

0.1682%

$1.23M

—

Douglas Earl Martin

SVP, General Counsel

—

$114.21K (3)

−$114.21K

488,267

0.1413%

$1.04M

—

Parker Geoffrey M.

CHIEF FINANCIAL OFFICER

$683.05 (1)

$95.96K (3)

−$95.27K

1,252,795

0.3626%

$2.66M

+7,743%

Beneski Benjamin Machinas

SVP, Chief Technical Officer

—

$62.51K (6)

−$62.51K

195,338

0.0565%

$414.12K

+1.6%

Mayo Stephen

Director

—

$42.86K (1)

−$42.86K

25,328

0.0073%

$53.70K

—

Yoshiyama Annie

SVP, Finance

—

$42.85K (3)

−$42.85K

124,517

0.0360%

$263.98K

+11.5%

MOORE TIMOTHY L.

Chief Technical Officer

—

$25.22K (1)

−$25.22K

250,713

0.0726%

$531.51K

—

SATO VICKI L

Director

—

162,575

0.0471%

$344.66K

—

Smith Lillian

VP, Corporate Counsel

—

140,390

0.0406%

$297.63K

+67.4%

CHEN YINLIN JACK

SVP, Finance

—

88,881

0.0257%

$188.43K

+14.7%

PF Equity Holdings 2 B.V. entity

10% owner

—

0.0000%

$0.00

−100.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Belldegrun Arie

24 May 2021

Director

Exercised, kept

379,066

$18.22

$6.91M

SCHMIDT ERIC THOMAS

24 May 2021

Chief Financial Officer

Exercised, kept

14,897

$18.22

$271.42K

Chang David D

24 May 2021

President and CEO

Exercised, kept

27,410

$18.22

$499.41K

Bhavnagri Veer

17 Dec 2020

General Counsel

Exercised, kept

51,500

$2.27

$116.91K

MOORE ALISON

13 Aug 2020

Chief Technical Officer

Exercised, kept

32,451

$2.27

$73.66K

MOORE ALISON

28 Jun 2019

Chief Technical Officer

Exercised, kept

27,816

$2.27

$63.14K

Show all 152 transactions →

Allogene Therapeutics, Inc.

By person

Individual transactions

What was left out